• Service
  • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • CER
  • About
Subscribe

Our Services

Strategy Consulting

  • Market Entry Strategy
  • Regulatory Strategy
  • Clinical Strategy
  • China Localization Strategy
  • Hainan Urgent Use Pathway
  • Innovation Pathway
  • Fast Track Pathway
  • Digital Health Consulting

Registration Affairs

  • Pre-market Registration
  • Modification Registration
  • Renewal Registration
  • Request for Classification
  • Legal Agent Representation
  • NMPA Expert Panel Meeting
  • NMPA Supplemental Notice

Quality Assurance

  • Postmarket Surveillance Compliance (IFU, Label, GSP)
  • Adverse Event Reporting
  • Recall Handling
  • Periodic Risk Evaluation Report
  • Annual QMS Self-Inspection Report
  • NMPA Inspections & Mock-Audit
  • QMS Establishment/Audit/Remediation
  • QA Gap Analysis
  • Factory Audit
  • Unique Device Identifier

Device Testing

  • China Local Type Testing
  • Device Modification Compliance Testing
  • Biocompatibility Testing
  • EMC Testing

Clinical Research Organization (CRO)

  • Clinical Trials/Research
  • Real-World Study
  • China CER & MDR CER
  • Clinical Evaluation Feasibility Assessment

Customized Training

  • China Regulatory Training
  • China QMS Training
  • China GCP Training
  • China Localization Training
  • Periodic Regulatory Updates Training

Other Services

  • Translation
  • Patent & Trademark
  • Distributor Evaluation & Audit
  • KOL Interview/Consultation
  • Investment
  • Global regulatory services
  • Service
  • Resources
    • Resources
    • Webinars
    • Upcoming Events
    • Documents Download
    • FAQ
    • NMPA Approval Report
  • News
  • About
  • CER
  • Subscribe
  • CN
  • US
  • Home
  • News
  • Regulations & Guidelines

News


  • Moments
  • Regulations & Guidelines
  • Fast Track Update
  • QMS/PMS
  • Other News
  • NMPA Monthly Newsletter
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021

Two Guidelines Issued By NMPA

2021-09-27

In order to help and guide the registration applicant to prepare the application materials of registered products to…

Your Feedback Counts! Contribute Your Wisdom To Guideline For Neurosurgical And Cardiovascular Surgical Devices

2021-09-23

On September 2, 2021, Guideline for Registration Review of Neurosurgical and Cardiovascular Surgical Devices - Knife, Scissors and…

Beneficial Policies In Hope City!

2021-09-22

To further optimize the business environment in Hainan Boao Lecheng pilot zone of international medical tourism (the Pilot…

Latest Clinical Exemption Catalogue Released!

2021-09-18

On September 18, 2021, NMPA has released measures for medical devices and IVD respectively. According to the Measures…

Results Of Sampling Inspection On Medical Devices Released

2021-09-17

On September 15, 2021, NMPA issued the results of sampling inspection on medical devices. A total of 12…

Oral Implant Surgery Navigation And Positioning Device Approved For Listing

2021-09-16

On September 14, 2021, NMPA has announced the approval of an innovative oral implant surgery navigation and positioning…

Draft Guidance For The Preparation Of Product Technical Requirements And The Submission Of Clinical Trial Data Released

2021-09-15

Recently, CMDE of NMPA issued two new guidelines, including Guidelines for Registration Review of Preparation of Product Technical…

A New Guideline For Intravascular Catheters Issued!

2021-09-08

On September 7, 2021, the NMPA released the Guideline on Technical Review on Predicate-Comparison Based Clinical Evaluation of…

A New Draft Guideline On Additive Manufacturing Metallic Implants Issued!

2021-09-07

Your feedback counts! On September 6, 2021, NMPA’s CMDE published the Draft Guideline for Registration Review on Quality Uniformity…

Two Provisions For Medical Device Registration And Filing Issued In One Day!

2021-09-02

On August 31, 2021, China issued the Provisions for Medical Device Registration and Filing and the Provisions for…

Five Products Enter The Pathway For Innovation And Priority Review

2021-09-02

On August 30, 2021, 5 products were approved by NMPA (former CFDA) to enter the innovation pathway and…

NMPA AE And Recall Report In August 2021

2021-09-02

In August, NMPA has released 28 medical device recalls, 14 of which are imported products. The table below…
« Prev...246...1314151617...Next »
Twitter Linkedin
United States
Email: info@bradyknowsmedical.com
Phone: +86 18600392020
China
Beijing Office: Room 1501-1502, East Ocean Centre, No. 24 A, Jianguomenwai Avenue, Chaoyang District, Beijing, China
Shanghai Office: Lingang New Zone, China (Shanghai) Pilot Free Trade Zone
Hainan Office: Boao Lecheng pilot zone of international medical tourism, Qionghai City, Hainan Province
Email: info@bradyknowsmedical.com
Phone: +86 18600392020 +86 10 65155991

©2025 Bradynuoen Beijing PharmTech Co Ltd All Rights Reserved.

京ICP备15042665号-7